Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.

Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA.

Vaccine. 2010 Aug 16;28(36):5850-6. doi: 10.1016/j.vaccine.2010.06.062. Epub 2010 Jun 30.

PMID:
20600481
2.

Safety, tolerability and efficacy of intradermal rabies immunization with DebioJectâ„¢.

Vescovo P, Rettby N, Ramaniraka N, Liberman J, Hart K, Cachemaille A, Piveteau LD, Zanoni R, Bart PA, Pantaleo G.

Vaccine. 2017 Mar 27;35(14):1782-1788. doi: 10.1016/j.vaccine.2016.09.069.

3.

Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine.

Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, Mohan K, Madhusudhan SK, Ravish HS.

Vaccine. 2010 May 28;28(24):4086-90. doi: 10.1016/j.vaccine.2010.03.064. Epub 2010 Apr 18.

PMID:
20403351
4.

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.

Vaccine. 2009 Jan 14;27(3):454-9. doi: 10.1016/j.vaccine.2008.10.077. Epub 2008 Nov 18.

PMID:
19022318
5.

Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients.

Tanisaro T, Tantawichien T, Tiranathanagul K, Susantitaphong P, Chirananthavat T, Praditpornsilpa K, Sitprija V, Eiam-Ong S.

Vaccine. 2010 Mar 11;28(12):2385-7. doi: 10.1016/j.vaccine.2010.01.003. Epub 2010 Jan 17.

PMID:
20085837
6.

Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.

Sudarshan MK, Madhusudana SN, Mahendra BJ, Narayana DH, Giri MS, Muhamuda K, Ravish HS, Venkatesh GM.

Natl Med J India. 2006 Jul-Aug;19(4):192-4.

PMID:
17100105
8.

A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.

Shiota S, Khawplod P, Ahmed K, Mifune K, Nishizono A.

Vaccine. 2008 Nov 25;26(50):6441-4. doi: 10.1016/j.vaccine.2008.08.068. Epub 2008 Sep 18.

PMID:
18804510
9.

Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.

Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, Ashwin BY, Padhi A, Manjula S, Patel PM.

Hum Vaccin Immunother. 2014;10(1):120-5. doi: 10.4161/hv.26456. Epub 2013 Sep 12.

10.

Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.

Kulkarni PS, Sapru A, D'costa PM, Pandit A, Madhusudana SN, Yajaman AB, Mangrule S, Gunale B, Bavdekar AR.

Vaccine. 2013 May 31;31(24):2719-22. doi: 10.1016/j.vaccine.2013.03.050. Epub 2013 Apr 12.

PMID:
23583817
11.

Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.

Roukens AH, Vossen AC, van Dissel JT, Visser LG.

Vaccine. 2008 Jun 25;26(27-28):3438-42. doi: 10.1016/j.vaccine.2008.04.033. Epub 2008 May 5.

PMID:
18511158
12.

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.

Bull World Health Organ. 2000;78(5):693-8.

13.

Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.

Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.

Int J Infect Dis. 2004 May;8(3):175-9.

14.

Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.

Sirikwin S, Likanonsakul S, Waradejwinyoo S, Pattamadilok S, Kumperasart S, Chaovavanich A, Manatsathit S, Malerczyk C, Wasi C.

Vaccine. 2009 Jul 9;27(32):4350-4. doi: 10.1016/j.vaccine.2009.03.027. Epub 2009 Apr 3.

PMID:
19487057
15.

Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.

Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, Montalban C, Lutsch C, Pepin-Covatta S, Le Mener V, Miranda M, Sabchareon A.

Acta Trop. 1998 Jul 30;70(3):317-33.

PMID:
9777717
16.

One or three intradermal injections within one week for rabies pre-exposure immunization.

Khawplod P, Wilde H, Sriaroon C, Chomchey P, Kamolthum T, Sitprija V.

Dev Biol (Basel). 2008;131:393-401.

PMID:
18634501
17.
18.

Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers.

Huang G, Liu H, Tang Q, Yu P, Shen X, Zhang Y, Liu X, Cao Q, Fu C, Liu B, Wang M.

Hum Vaccin Immunother. 2014;10(1):114-9. doi: 10.4161/hv.26264. Epub 2013 Sep 5.

19.

Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.

Kositprapa C, Limsuwun K, Wilde H, Jaijaroensup W, Saikasem A, Khawplod P, Kri-aksorn U, Supich C.

Clin Infect Dis. 1997 Sep;25(3):614-6.

PMID:
9314448
20.

Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.

Wang LY, Sun MP, Zhang XC, Suo LD, Xu RH, Zou YJ, Zuo LB, Qi H.

Vaccine. 2011 Mar 24;29(15):2679-81. doi: 10.1016/j.vaccine.2011.01.053. Epub 2011 Feb 3.

PMID:
21296694

Supplemental Content

Support Center